An emerging pharmaceutical company based in Europe showed strong Phase IIb results for its lead compound, seeking a rigorous evaluation of the market opportunity and a rationale to support either commercialisation alone, or with a partner in the US. In addition, an internal consensus was needed on the potential claims and priorities for successful commercialisation
An opportunity assessment was commissioned to provide input for the commercial strategy of a new central nervous system (CNS) product, requiring unique labeling, in a highly competitive market. Elements of the project included detailed market landscape; qualified and nonaligned experts to complete information gaps from desk research in the landscape and provide an initial reaction to a target product profile; structure, content, and moderation of an internal C-suite workshop; quantitative research and a forecast model; claims structure and company vision statement; integrated executive presentation with detailed back-up
The internal workshop was prescheduled for less than 3 weeks from the kick-off meeting for the project
The Cello Health project team created the core elements; seeking approval of the following at the kick-off meeting (Jan 2):
The Cello Health team stayed one step ahead of the timeline in preparation of the materials to meet all deadlines.
Summary notes from the workshop were issued and the project continued with the following along a more conventional timeline:
The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us todayContact us